Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C E Caldon

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Molecular Microbiology|August 8, 2001
Evolution of a molecular switch: universal bacterial GTPases regulate ribosome functionC E Caldon, P Yoong, P E March
Endocrine-Related Cancer|February 16, 2020
Cyclin E1 and cyclin E2 in ER+ breast cancer: prospects as biomarkers and therapeutic targetsH H Milioli, S Alexandrou, E Lim, et al.
Oncogene|June 30, 2007
Wilms' tumor protein 1: an early target of progestin regulation in T-47D breast cancer cells that modulates proliferation and differentiationC E Caldon, C S L Lee, R L Sutherland, et al.
Oncogene|July 4, 2012
Functional characterization of cancer-associated Gab1 mutationsC Ortiz-Padilla, D Gallego-Ortega, B C Browne, et al.
Molecular Endocrinology (Baltimore, Md.)|June 4, 2010
The antiproliferative effects of progestins in T47D breast cancer cells are tempered by progestin induction of the ETS transcription factor Elf5H N Hilton, M Kalyuga, M J Cowley, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Molecular Microbiology|August 8, 2001
Evolution of a molecular switch: universal bacterial GTPases regulate ribosome functionC E Caldon, P Yoong, P E March
Endocrine-Related Cancer|February 16, 2020
Cyclin E1 and cyclin E2 in ER+ breast cancer: prospects as biomarkers and therapeutic targetsH H Milioli, S Alexandrou, E Lim, et al.
Oncogene|June 30, 2007
Wilms' tumor protein 1: an early target of progestin regulation in T-47D breast cancer cells that modulates proliferation and differentiationC E Caldon, C S L Lee, R L Sutherland, et al.
Oncogene|July 4, 2012
Functional characterization of cancer-associated Gab1 mutationsC Ortiz-Padilla, D Gallego-Ortega, B C Browne, et al.
Molecular Endocrinology (Baltimore, Md.)|June 4, 2010
The antiproliferative effects of progestins in T47D breast cancer cells are tempered by progestin induction of the ETS transcription factor Elf5H N Hilton, M Kalyuga, M J Cowley, et al.
Pageof 1